293 related articles for article (PubMed ID: 26047984)
1. Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network.
Briggs CE; Wang Y; Kong B; Woo TU; Iyer LK; Sonntag KC
Brain Res; 2015 Aug; 1618():111-21. PubMed ID: 26047984
[TBL] [Abstract][Full Text] [Related]
2. miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.
Kim W; Lee Y; McKenna ND; Yi M; Simunovic F; Wang Y; Kong B; Rooney RJ; Seo H; Stephens RM; Sonntag KC
Neurobiol Aging; 2014 Jul; 35(7):1712-21. PubMed ID: 24559646
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-128 Protects Dopamine Neurons from Apoptosis and Upregulates the Expression of Excitatory Amino Acid Transporter 4 in Parkinson's Disease by Binding to AXIN1.
Zhou L; Yang L; Li YJ; Mei R; Yu HL; Gong Y; Du MY; Wang F
Cell Physiol Biochem; 2018; 51(5):2275-2289. PubMed ID: 30537735
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
5. Cell-Specific RNA Quantification in Human SN DA Neurons from Heterogeneous Post-mortem Midbrain Samples by UV-Laser Microdissection and RT-qPCR.
Duda J; Fauler M; Gründemann J; Liss B
Methods Mol Biol; 2018; 1723():335-360. PubMed ID: 29344870
[TBL] [Abstract][Full Text] [Related]
6. Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson's disease striatum.
Nair VD; Ge Y
Neurosci Lett; 2016 Aug; 629():99-104. PubMed ID: 27369327
[TBL] [Abstract][Full Text] [Related]
7. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
[TBL] [Abstract][Full Text] [Related]
8. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
Lu L; Neff F; Fischer DA; Henze C; Hirsch EC; Oertel WH; Schlegel J; Hartmann A
Neurobiol Dis; 2006 Aug; 23(2):409-21. PubMed ID: 16753304
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis of microRNA expression in Parkinson's disease.
Hao B; Chen X; Dai D; Zou C; Wu X; Chen J
Mol Med Rep; 2015 Feb; 11(2):1079-84. PubMed ID: 25371140
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
Liang CL; Wang TT; Luby-Phelps K; German DC
Exp Neurol; 2007 Feb; 203(2):370-80. PubMed ID: 17010972
[TBL] [Abstract][Full Text] [Related]
11. Age-related gene expression changes in substantia nigra dopamine neurons of the rat.
Parkinson GM; Dayas CV; Smith DW
Mech Ageing Dev; 2015 Jul; 149():41-9. PubMed ID: 26065381
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
Luk KC; Rymar VV; van den Munckhof P; Nicolau S; Steriade C; Bifsha P; Drouin J; Sadikot AF
J Neurochem; 2013 Jun; 125(6):932-43. PubMed ID: 23331067
[TBL] [Abstract][Full Text] [Related]
13. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.
Chung CY; Seo H; Sonntag KC; Brooks A; Lin L; Isacson O
Hum Mol Genet; 2005 Jul; 14(13):1709-25. PubMed ID: 15888489
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.
Su L; Wang C; Zheng C; Wei H; Song X
BMC Med Genomics; 2018 Apr; 11(1):40. PubMed ID: 29653596
[TBL] [Abstract][Full Text] [Related]
15. Regulatory miRNA-mRNA Networks in Parkinson's Disease.
Santos-Lobato BL; Vidal AF; Ribeiro-Dos-Santos Â
Cells; 2021 Jun; 10(6):. PubMed ID: 34204164
[TBL] [Abstract][Full Text] [Related]
16. Impaired motor coordination in Pitx3 overexpression mice.
Kim H; Quan X; Seong Y; Kim J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1211-8. PubMed ID: 24680684
[TBL] [Abstract][Full Text] [Related]
17. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
George G; Valiya Parambath S; Lokappa SB; Varkey J
Gene; 2019 May; 697():67-77. PubMed ID: 30776463
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease.
Lu J; Xu Y; Quan Z; Chen Z; Sun Z; Qing H
Neuroscience; 2017 Dec; 365():70-82. PubMed ID: 28964753
[TBL] [Abstract][Full Text] [Related]
19. Systemic Analysis of miRNAs in PD Stress Condition: miR-5701 Modulates Mitochondrial-Lysosomal Cross Talk to Regulate Neuronal Death.
Prajapati P; Sripada L; Singh K; Roy M; Bhatelia K; Dalwadi P; Singh R
Mol Neurobiol; 2018 Jun; 55(6):4689-4701. PubMed ID: 28710704
[TBL] [Abstract][Full Text] [Related]
20. Dicer and microRNAs protect adult dopamine neurons.
Chmielarz P; Konovalova J; Najam SS; Alter H; Piepponen TP; Erfle H; Sonntag KC; Schütz G; Vinnikov IA; Domanskyi A
Cell Death Dis; 2017 May; 8(5):e2813. PubMed ID: 28542144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
